Kohei Yoshioka

Recent publications · Crossref

5 total works indexed

1. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

   · 2020 · cited 3,899x

2. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

   · 2010 · cited 3,265x

3. TGF-β signalling from cell membrane to nucleus through SMAD proteins

   · 1997 · cited 3,082x

4. A bacterium that degrades and assimilates poly(ethylene terephthalate)

   · 2016 · cited 2,891x

5. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,788x

via Crossref · CC0